Literature DB >> 35482075

Should we take precautions to avoid respiratory compromise while delaying CPAP resumption following transsfenoidal surgery? An alternative approach in a patient with severe obstructive sleep apnea: case report.

Yılmaz Yenigün1, Anıl Özonur2, Kamil Mehmet Tuğrul3, Uğur Özbek3, Nurperi Gazioğlu4.   

Abstract

BACKGROUND: We describe a patient with severe obstructive sleep apnea scheduled for transsfenoidal surgery. Early postoperative use of continuous positive airway pressure (CPAP) was considered unsafe because increased risk of intracranial complications.
METHODS: Aiming to bypass the upper airway obstruction and thus avoid CPAP, a 6-mm nasopharyngeal airway was introduced by the surgical team under endoscopic vision. In the postoperative period and during follow-up, patient and his family did not complain about apnea/hypopnea episodes and nasopharyngeal airway was tolerated comfortably.
CONCLUSION: We recommend this technique as an alternative in obstructive sleep apnea patients undergoing transsfenoidal surgery.
© 2022. The Author(s), under exclusive licence to Springer-Verlag GmbH Austria, part of Springer Nature.

Entities:  

Keywords:  Case report; Continuous positive airway pressure; Obstructive sleep apnea; Transsfenoidal surgery

Mesh:

Year:  2022        PMID: 35482075     DOI: 10.1007/s00701-022-05213-x

Source DB:  PubMed          Journal:  Acta Neurochir (Wien)        ISSN: 0001-6268            Impact factor:   2.216


  14 in total

1.  Risk of post-operative pneumocephalus in patients with obstructive sleep apnea undergoing transsphenoidal surgery.

Authors:  Gabrielle A White-Dzuro; Ken Maynard; Scott L Zuckerman; Kyle D Weaver; Paul T Russell; Matthew J Clavenna; Lola B Chambless
Journal:  J Clin Neurosci       Date:  2016-02-22       Impact factor: 1.961

2.  Resumption of Positive-Pressure Ventilation Devices for Obstructive Sleep Apnea following Transsphenoidal Surgery: An Institutional Experience of a Surgical Cohort.

Authors:  Nicholas Gravbrot; Heidi Jahnke; William L White; Andrew S Little
Journal:  J Neurol Surg B Skull Base       Date:  2019-05-17

3.  Pneumocephalus with BiPAP use after transsphenoidal surgery.

Authors:  Jonathan C Kopelovich; Gabriel O de la Garza; Jeremy D W Greenlee; Scott M Graham; Chiedozie I Udeh; Erin K O'Brien
Journal:  J Clin Anesth       Date:  2012-05-22       Impact factor: 9.452

Review 4.  Obstructive sleep apnea syndrome and perioperative complications: a systematic review of the literature.

Authors:  Tajender S Vasu; Ritu Grewal; Karl Doghramji
Journal:  J Clin Sleep Med       Date:  2012-04-15       Impact factor: 4.062

5.  Postoperative complications in patients with obstructive sleep apnea syndrome undergoing hip or knee replacement: a case-control study.

Authors:  R M Gupta; J Parvizi; A D Hanssen; P C Gay
Journal:  Mayo Clin Proc       Date:  2001-09       Impact factor: 7.616

6.  Cerebrospinal fluid leak and meningitis associated with nasal continuous positive airway pressure therapy.

Authors:  Tomasz J Kuzniar; Benjamin Gruber; Gökhan M Mutlu
Journal:  Chest       Date:  2005-09       Impact factor: 9.410

7.  Postoperative complications in patients with obstructive sleep apnea: a retrospective matched cohort study.

Authors:  Pu Liao; Balaji Yegneswaran; Santhira Vairavanathan; Paul Zilberman; Frances Chung
Journal:  Can J Anaesth       Date:  2009-11       Impact factor: 5.063

8.  [Two cases of pneumocephalus following noninvasive continuous positive airway ventilation after transsphenoidal neurosurgery].

Authors:  D Zlotnik; G Taylor; A Simmoneau; V Viot-Blanc; J-M Devys
Journal:  Ann Fr Anesth Reanim       Date:  2014-04-13

Review 9.  A systemic review of obstructive sleep apnea and its implications for anesthesiologists.

Authors:  Sharon A Chung; Hongbo Yuan; Frances Chung
Journal:  Anesth Analg       Date:  2008-11       Impact factor: 5.108

10.  Pneumocephalus associated with nasal continuous positive airway pressure in a patient with sleep apnea syndrome.

Authors:  N N Jarjour; P Wilson
Journal:  Chest       Date:  1989-12       Impact factor: 9.410

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.